INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1356994684-epigenetics-rna]( "Methods for mRNA Poly(A) Sizing")
Methods for mRNA Poly(A) SizingThis study used Oxford Nanopore Technologies' Direct RNA Sequencing Kit and obtained successful sizing of poly(A) tail regions. The results are presented in a histogram and table format.
-
![GettyImages-114414844-Centrifugation]( "New Instrumentation Expands Sediment Velocity AUC’s Utility")
New Instrumentation Expands Sediment Velocity AUC’s UtilityPurified adeno-associated viruses (AAVs) are prepared as a variety capsid species that must be characterized and quantified to ensure safety and efficacy.
-
![GettyImages-115025703-centrifugation]( "Identify And Quantify AAV Fill States Using Analytical Centrifugation")
Identify And Quantify AAV Fill States Using Analytical CentrifugationPurified AAVs are prepared as a variety capsid species. To ensure gene therapy safety and efficacy, it is crucial to characterize and quantify those species.
-
![Outsourcing High Potent Oral Solid Dose Late-Stage Development]( "Outsourcing High Potent Oral Solid Dose Late-Stage Development: CDMO Insights")
Outsourcing High Potent Oral Solid Dose Late-Stage Development: CDMO InsightsView the webinar to discover outsourcing options for highly potent oral solid dose therapies, and learn how CDMOs can transfer, handle and deliver their product to clinic and to market.
-
Tips For Viral Vector Production4/16/2024
Learn about how meticulous purification optimization can maximize recovery and impurity removal by leveraging scalable downstream technologies to meet regulatory and process economy requirements.
-
What Is A Viral Vector?4/16/2024
Review a novel adenovirus production process that offers scalable, single-use equipment-compatible solutions, reducing production time and cross-contamination risks.
-
Reduce Costly Scale-Up Problems4/11/2024
Scaling a new drug formulation from development to manufacturing often presents challenges, but there are ways to minimize deviations and streamline your transition.
-
Optimizing Pediatric Product Development For Commercialization Success4/10/2024
Ensuring medication adherence in pediatric patients presents challenges for pharmacotherapy. Explore various dosing solutions and learn how to streamline your pediatric development journey.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-600393496-bacteria]( "Microbial CDMO Services")
With over 30+ years’ of experience in microbial CDMO services, one of our core areas of expertise is the development of large-scale processes for recombinant protein expression in microbial hosts (E.coli, P.pastoris and S.cerevisiae).
-
![GettyImages-1400218353-eco_environment_city_green_sustainable]( "Small Is Powerful, Small Is Green")
As the pharmaceutical industry innovates and evolves, learn more about how Nanoform can play a critical role in empowering your company's journey to net zero.
-
![Fill finish vials GettyImages-1298781737]( "Introducing Lyophilization And Sterile Manufacturing")
The addition of global Sterile Fill-Finish and extensive lyophilization capabilities ensures that we are able to build on our enviable reputation and deliver on our promise of delivering life-changing therapies to patients worldwide.
-
![iStock-136140244-lab-pharma-equipment-process]( "Process Development")
When you choose AGC Biologics as your partner, you will benefit from our many years of biologics process development expertise. Our experienced team is dedicated to the successful completion of your project and committed to helping you meet your goals.
-
![Chromatography GettyImages-1392302602]( "Drug Characterization And Release Testing Services")
Learn how leveraging the expertise and flexibility of a partner empowers you to ensure regulatory compliance from the outset, with thorough characterization starting at the earliest stages.
